Determination of procoagulant activity in human normal immunoglobulin preparations for therapeutic use by FXIa chromogenic assay: Evaluation of test kit sensitivity, reference standard performance and product formulation effects on the FXIa assay.

Authors :: Behr-Gross, M-E.
Le Tallec, D.
Sinitskaya, N.
Milne, C.
Etscheid, M.
Source :: Pharmeuropa Bio & Scientific Notes; Mar2024, p27-75, 49p
Publication Year :: 2024

Tools